About Vysali Pharmaceuticals Ltd
Data last updated: 25 July 2025
Vysali Pharmaceuticals Ltd is a public limited company based in Ernakulam, Kerala, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 29 October 1979, the company has been in operation for over 47 years.
Registered with ROC Ernakulam under CIN U24231KL1979PLC003112.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.43 Cr. It is led by directors including Kizhakkekara Kuriakose Jose and Valath Subramanian Sheelavelappan.
Last AGM: 26 November 2022. Financial statements filed for year ended 31 March 2022. Office: Ix/639 Vysali Road Edathala P O, Ernakulam, Kerala, India – 683561.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.16 Cr, a decline of 38.63% compared to the previous year.
As per MCA filings, the company has open charges of ₹30.26 Cr and satisfied charges of ₹19.46 Cr on record.
The company is currently under liquidation - its assets are being sold to settle outstanding debts. It may lack the legal capacity to fulfil new agreements, and creditors are prioritised in the distribution of proceeds. The last known website on record is vysalipharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressIx/639 Vysali Road Edathala P O, Ernakulam, Kerala, India – 683561
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Business Activity of Vysali Pharmaceuticals Ltd
Vysali Pharmaceuticals Ltd operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Detailed business activity records for Vysali Pharmaceuticals Ltd
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Vysali Pharmaceuticals Ltd
Vysali Pharmaceuticals Ltd is audited by Chithrabhanu Kaplingat for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Chithrabhanu Kaplingat | Locked | Locked | Locked |
Complete auditor history for Vysali Pharmaceuticals Ltd
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vysali Pharmaceuticals Ltd
Vysali Pharmaceuticals Ltd is currently managed by 4 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kizhakkekara Kuriakose Jose | Irp/Rp/Liquidator | 26 Feb 2024 | 2 Years 4 Months | As last reported |
| Valath Subramanian Sheelavelappan | Additional Director | 27 Sep 2019 | 6 Years 9 Months | As last reported |
| Savithri Krishnan | Whole-Time Director | 29 Oct 1979 | 46 Years 8 Months | As last reported |
| Alathur Damodaran Krishnan | Managing Director | 29 Oct 1979 | 46 Years 8 Months | As last reported |
Financials of Vysali Pharmaceuticals Ltd FY 2022 filings available
Vysali Pharmaceuticals Ltd reported revenue of ₹2.16 Cr (down 38.63% YoY) for FY 2022.
Ten-year financial statements for Vysali Pharmaceuticals Ltd
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Vysali Pharmaceuticals Ltd
Shareholding and ownership data for Vysali Pharmaceuticals Ltd
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vysali Pharmaceuticals Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2019 | Others | ₹3 Cr | Open |
| 25 Oct 2007 | Kerala State Industrial Development Corporation Limited | ₹5.59 Cr | Open |
| 24 Oct 2007 | Kerala State Industrial Development Corporation Limited | ₹5.59 Cr | Open |
| 14 Jun 2007 | Kerala State Industrial Development Corpn Ltd | ₹5.59 Cr | Open |
| 13 Jun 2007 | Kerala State Industrial Development Corpn Ltd | ₹5.59 Cr | Open |
Total charge records: 23 View all charges
Employees and EPFO Compliance at Vysali Pharmaceuticals Ltd
Vysali Pharmaceuticals Ltd has a workforce of 0 employees as of Apr 07, 2024.
Employee and EPFO history for Vysali Pharmaceuticals Ltd
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Vysali Pharmaceuticals Ltd
GST registrations and filing compliance for Vysali Pharmaceuticals Ltd
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Vysali Pharmaceuticals Ltd
Credit ratings, litigation, and regulatory alerts for Vysali Pharmaceuticals Ltd
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vysali Pharmaceuticals Ltd
MSME payment history for Vysali Pharmaceuticals Ltd
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vysali Pharmaceuticals Ltd
Corporate group structure for Vysali Pharmaceuticals Ltd
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vysali Pharmaceuticals Ltd
MCA filings and documents for Vysali Pharmaceuticals Ltd
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Vysali Pharmaceuticals Ltd
Frequently Asked Questions about Vysali Pharmaceuticals Ltd
Vysali Pharmaceuticals Ltd is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Vysali Pharmaceuticals Ltd is a company under liquidation, formerly operating as a public limited company in the pharma sector based in Ernakulam, Kerala, India. It was incorporated on 29 October 1979 and is registered under CIN U24231KL1979PLC003112. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Vysali Pharmaceuticals Ltd reported revenue of ₹2.16 Cr for FY 2022 (down 38.63% YoY).
The current directors of Vysali Pharmaceuticals Ltd are:
- Kizhakkekara Kuriakose Jose - Irp/Rp/Liquidator
- Valath Subramanian Sheelavelappan - Additional Director
- Savithri Krishnan - Whole-Time Director
- Alathur Damodaran Krishnan - Managing Director
The CIN (Corporate Identification Number) of Vysali Pharmaceuticals Ltd is U24231KL1979PLC003112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vysali Pharmaceuticals Ltd has open charges of ₹30.26 Cr and satisfied charges of ₹19.46 Cr as per latest MCA filings.